Previous 10 |
home / stock / bimuf / bimuf news
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 14, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the Company has discovered certain cannabinoids that block replication of SARS-CoV-2, the coronavirus that causes COVID-19. In a cell-ba...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 9, 2020 / Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the appointment of Dr. H. Michael Shepard to its Board of Directors. Dr. Shepard was a 2019 recipient of the Lasker Award for medical re...
Editors' Note: This is the transcript version of the podcast we published last Wednesday with Howard Lee. Please note that due to time and audio constraints, transcription may not be perfect. We encourage you to listen to the podcast, embedded below, if you need any clarification. We ho...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . Prior to becoming CEO at Seattle-based SōRSE Technology , a food and beverage tech company using emulsion technology, Howard Lee fou...
News, Short Squeeze, Breakout and More Instantly...
Biommune Technologies Inc Company Name:
BIMUF Stock Symbol:
OTCMKTS Market:
VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes following its recent capital raise. First,...
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 17, 2021 / Pascal Biosciences Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids...
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. (" Pascal " or the " Company ") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr. Patrick Gray, CEO of Pascal Biosciences,...